MNOV - Medicinova, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.24 0.01 (0.81%) --- --- --- 0.0 (0.0%) 0.02 (1.63%) --- 0.0 (0.0%)

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.07
Diluted EPS:
-0.07
Basic P/E:
-17.8571
Diluted P/E:
-17.8571
RSI(14) 1m:
50.0
VWAP:
1.25
RVol:
1.7256

Events

Period Kind Movement Occurred At

Related News